Best ways to give colistin for tough infections in the ICU
Part of Infections clinical trials.
This study tests different ways of giving the antibiotic colistin to patients in the ICU with infections that are hard to treat. The goal is to find the best dosing schedule to help you fight the infection more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are currently in an intensive care unit (ICU).
- You are being treated with the antibiotic colistin (also called CMS) for a tough-to-treat bacterial infection.
- You are not allergic to colistin.
- You are not pregnant or breastfeeding.
- You do not have myasthenia gravis (a muscle weakness disease) and are not taking certain muscle relaxant drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a way to give the antibiotic colistin (which fights hard-to-treat infections) more personally to premature newborns, based on each baby's own body. The goal is to make the treatment safer and more effective for babies who are very sick in the neonatal intensive care unit (NICU).
This trial tests if giving a medication (colistin) both through an IV and as a mist you breathe in works better for lung infections caused by bacteria that are hard to treat with standard antibiotics. It may help patients who have these tough bacteria and are in the hospital.
This trial tests if inhaling a medication called colistin can prevent ventilator-associated pneumonia (a lung infection) in patients who are on a breathing machine. It aims to reduce the risk for those at high risk of getting an infection from drug-resistant bacteria.
This trial tests how the amount of liquid mixed with colistin affects treatment when inhaled by patients on ventilators. The goal is to find the best way to give this antibiotic therapy.
This study is looking at bacteria from hospital patients that are hard to treat because they resist many antibiotics, including a last-resort medicine called colistin. By testing these bacteria, researchers hope to find better ways to stop the spread of drug-resistant infections.
This study tests which of two antibiotic combinations works better at clearing infections caused by multi-drug-resistant bacteria in adults, including those with weakened immune systems. It aims to find a more effective treatment option.
Hear when a new Critical Ill Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.